3 news items
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
GILD
7 May 24
June 3, 2024
8:00 – 11:00 AM CDT
Gilead Sciences Announces First Quarter 2024 Financial Results
GILD
25 Apr 24
reports on Form 8-K. In addition, Gilead makes estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses
Gilead Sciences Announces Completion of Acquisition of CymaBay
CBAY
GILD
22 Mar 24
and Exchange Commission, including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K. All forward-looking
- Prev
- 1
- Next